CXCR4 and diabetes mellitus: Circulating ASC level was analyzed before and 8 h after therapy with the CXCR4 antagonist plerixafor in two patients with diabetes: a man aged 68 with a BMI of 25.3 kg/m2 and a woman aged 69 with BMI of 33.6 kg/m2.